Tondo, P.; Scioscia, G.; De Pace, C.C.; Murgolo, F.; Maci, F.; Stella, G.M.; Pescatore, D.; Foschino Barbaro, M.P.; Lacedonia, D.
Gender Differences Are a Leading Factor in 5-Year Survival of Patients with Idiopathic Pulmonary Fibrosis over Antifibrotic Therapy Reduction. Life 2025, 15, 106.
https://doi.org/10.3390/life15010106
AMA Style
Tondo P, Scioscia G, De Pace CC, Murgolo F, Maci F, Stella GM, Pescatore D, Foschino Barbaro MP, Lacedonia D.
Gender Differences Are a Leading Factor in 5-Year Survival of Patients with Idiopathic Pulmonary Fibrosis over Antifibrotic Therapy Reduction. Life. 2025; 15(1):106.
https://doi.org/10.3390/life15010106
Chicago/Turabian Style
Tondo, Pasquale, Giulia Scioscia, Cosimo C. De Pace, Fabiola Murgolo, Federica Maci, Giulia M. Stella, Dalila Pescatore, Maria Pia Foschino Barbaro, and Donato Lacedonia.
2025. "Gender Differences Are a Leading Factor in 5-Year Survival of Patients with Idiopathic Pulmonary Fibrosis over Antifibrotic Therapy Reduction" Life 15, no. 1: 106.
https://doi.org/10.3390/life15010106
APA Style
Tondo, P., Scioscia, G., De Pace, C. C., Murgolo, F., Maci, F., Stella, G. M., Pescatore, D., Foschino Barbaro, M. P., & Lacedonia, D.
(2025). Gender Differences Are a Leading Factor in 5-Year Survival of Patients with Idiopathic Pulmonary Fibrosis over Antifibrotic Therapy Reduction. Life, 15(1), 106.
https://doi.org/10.3390/life15010106
